Dr. Anoop Misra Diabetologist in Delhi

Dr. Anoop Misra

Diabetologist, Delhi


  • 2 Hospitals


Dr. Anoop Mishra is the Director and Head of department of Diabetes and Metabollic Diseases, Fortis Hospitals, Delhi. He is a versatile personality with distinctive achievements in clinical service, teaching, research, community health activities and medical education and health uplift of poor people. He was a professor in Internal Medicine at All India Institute of Medical sciences, New Delhi. He also served as faculty at University of Texas, Southwestern Medical Center at Dallas.  Dr. Anoop Mishra is an active member of World Health Organization and Indian Council of Medical Research Expert Groups for Childhood Obesity, Fatty Liver, Diabetes and Gestational Diabetes.


  • Diabetology

  • Endocrinology


  • Obesity
  • Metabolic Diseases


  • MBBS from AIIMS, Distinction in Forensic Science, 2nd in Surgery
  • MD from AIIMS, passed with top honors
  • Secretary to Magnusons Global Diabetes Research Alliance

Practice Information

Fortis Flt. Lt. Rajan Dhall Hospital, Delhi

Fortis Flt. Lt. Rajan Dhall Hospital, Delhi

Pocket 1 Aruna Asaf Ali Marg, Sector B, Vasant Kunj, Delhi, Delhi - 110070

Fortis C-DOC, Delhi

Fortis C-DOC, Delhi

Opp Nehru Place, B-16, Chirag Enclave, Delhi, Delhi - 110017

Achievements & Contributions

  • Genetic studies of fatty liver and fat free mass, ICMR, Rs. 20 lacs, 2009.
  • Trans Fatty Acids: Effects of Insulin Resistance and Lipids, DST, Rs. 20 lacs, 2009.
  • Autologous stem cell trail in diabetic foot, 2009.
  • Investigations of lean phenotype of diabetes in Asian Indians. A multi-site collaborative study, Investigator-initiated grant, MSD, 2009.
  • Intervention trial of almonds in patients with type 2 diabetes, Rs. 30 lacs, Almond Board of California.
  • Clinical Research: Sugar free Ice cream in Diabetic (Type-2) subjects, Mother Dairy & Vegetables Pvt. Ltd., R. 5 lacs, 2008.
  • To study the validity of bioelectrical impedance for assessment of body composition in Asian Indians, Rs. 9 lacs, 2008.
  • Health Effects of Pistachio nuts, Rs. 40 lacs, 2008.
  • Trends in knowledge, attitude and practice of nutrition in schoolchildren and their parents (Project TEACHER), Rs. 30 lacs, 2006-9.
  • Targeted Intervention in Schoolchildren for Prevention of Obesity and Diabetes, World Diabetes Foundation, Denmark, US $ 1,70, 000, 2005-10.
  • Randomised trial of Fenofibrate in the metabolic syndrome, Rs. 6 lacs, 2007.
  • To Study the Effect of a Protein, Multiple fiber Micronutrient Fortified Supplement on Diabetic Patients, Rs. 5 lacs 2005-7.
  • Double blind randomized placebo-controlled clinical trial of herbal compound MA-579 in patients with non alcoholic fatty liver diseases, Maharishi Ayurveda Products, Rs. 3 lacs, 2005-7.
  • Health Education in school children with reference to obesity, diabetes, nutrition and physical activity (Project CHETNA), Rs. 7 lacs, 2006-8.
  • Double blind randomized placebo-controlled clinical trial of herbal compound MA-471 on metabolic profile of Type 2 diabetic patients, Maharishi Ayurveda Products, Rs. 3.75 lacs, 2005-7.
  • Evaluation of efficacy and safety of Wosulin Biphasic (Human Insulin Biphas regular. NPH, 30:70) (rDNA origin) for control of hyperglycemia in subjects with type 2 diabetes mellitus-phase IV study, Wockhardt Pharmaceutical Company, Rs. 2. 26lacs, 2005-6.
  • Investigation of genetic basis, and gene-lifestyle interactions in generalized and regional obesity and insulin resistance in Asian Indians, Department of Biotechnology, Government of India, Rs 70 lacs (US $140,000), 2004-8.
  • A country-wide survey of nutrition disorders related to non-communicable disease in elderly women (A Multi-site 10 center Study). Department of Science and Technology, Ministry of Science and Technology, Government of India. Rs. 20 lacs (Us $ 40,000), 2004-8.
  • Genetic polymorphism of cholesterol ester transfer protein (CETP) and its association with HDL-c levels in healthy Indian subjects, Submitted to Indian Council of Medical Research, Rs 10 lacs ($ 20,000), 2004-7.
  • A population based study of diabetes and metabolic correlates of cardiovascular risk factors among Asian Indians (Multi-site International Collaboration Study), Texas A&M University subcontracted by CDC, Atlanta, GA, USA, Rs. 20 lacs (US $ 40,000), 2004 -
  • Assessment of nutritional and antioxidant enzyme status in mechanically ventilated critically III patients. Effect on mortality and strategies for improving nutritional support. Department of Science and Technology, Ministry of Science and Technology, Government of India, Rs. 31 lacs, 2003 -
  • Estimation of prevalence of hyperinsulinemia, hyperlipidemia, hypertension, obesity and glucose intolerance and their correlation to nutrition status (with special reference to amount and type of dietary fat and fibre intake), and other lifestyle factors in urban adolescent and young adult population, Department of Science and Technology, Ministry of Science and Technology, Government of India, Rs. 14 lacs, 2000 -04.
  • Study of the relationships between growth hormone-insulin like growth factor-1 axis and hypothalamo-pituitary-adrenal axis with body composition, insulin sensitivity, subclinical inflammation and cytokines in Asian Indians, Department of Science and Technology, Ministry of Science and Technology, Government of India, Rs. 9 lacs, 2004 -
  • Strategies for prevention and management of medical problems in post-menopausal women of urban slums with particular reference to nutrition, osteoporosis, cataract, and hypertension, Department of Science and Technology, Ministry of Science and Technology, Government of India, Rs. 9 lacs, 2000-02.
  • Experimental and clinical evaluation of herbal anti-diabetic compound formulation 'Amree Plus' for its mode of action and toxicity, AIMIL pharmaceutical company, Rs. 6 lacs, 2001 -
  • Open randomized clinical trial comparing Ayurvedic herbal compound, lipomap (MA-1596) with lovastatin in hypercholesterolemia subject, Maharishi Ayurveda Products, Rs. 4 lacs, 2000 -
  • Double blind randomized placebo controlled clinical trial of herbal compound MA-471 on metabolic profile in diabetic patients, Maharishi Ayurveda Products, Rs. 2 lacs, 2001 -
  • Correlation of polymorphism of apolipoprotein E gene with dyslipidemia and body composition Northern Indian subject, Indian Council of Medical Research, Rs. 3 lacs, 2001
  • In the area of diabetes and cardiovascular disease his contributions have been immense and he has been awarded with several prestigious orations and awardsS.N. Tripathy Memorial Oration (2003) 
  • Prof. Austin E. Doyle Oration (2004) 
  • Dr K.L. Wig Oration (2005) 
  • Sam G. Moses Oration (2005) 
  • Prof. B.R. Sengupta Oration (2005)
  • Searle Oration (2006) 
  • Amar Sen Oration (2006)
  • D.K. Pal Chowdhary Oration (2006)
  • Kamala Puri Sabharwal Oration (2007)
  • Dr O.P.Gupta Oration (2007) 
  • Amrit Mody Oration (2008)
  • V Ramalingaswami Oration (2009) 
  • As a UG and PG student he received awards for highest marks in many subjects
  • Padma Shri (2007) awarded by President of India, Dr. BC Roy Award (2006)
  • Spirit of Humanity Award, Americare Foundation 2010,Swastha Bharat Samman, a Zee News initiative
  • Member of editorial boards of 10 international journals

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Anoop Misra and his staff know how they are doing and how they can improve their services.